Detalhe da pesquisa
1.
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care.
J Rheumatol
; 51(4): 378-389, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38224992
2.
Highly accessible AU-rich regions in 3' untranslated regions are hotspots for binding of regulatory factors.
PLoS Comput Biol
; 13(4): e1005460, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28410363
3.
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration.
Arthritis Res Ther
; 25(1): 205, 2023 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858143
4.
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration.
Semin Arthritis Rheum
; 56: 152081, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35985172
5.
Corrigendum to 'Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration' [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081].
Semin Arthritis Rheum
; 58: 152141, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463635
6.
cWords - systematic microRNA regulatory motif discovery from mRNA expression data.
Silence
; 4(1): 2, 2013 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23688306
7.
On the accuracy of short read mapping.
Methods Mol Biol
; 1038: 39-59, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23872968